Literature DB >> 22084991

In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii.

Y Smani1, R López-Rojas, J Domínguez-Herrera, F Docobo-Pérez, S Martí, J Vila, J Pachón.   

Abstract

Limited data on relative fitness and virulence of antimicrobial-resistant Acinetobacter baumannii are known. We aimed to study the virulence and fitness cost of ciprofloxacin-resistance in A. baumannii (CipR) compared with the susceptible parental wild-type strain (CipS). Human lung epithelial cells were infected with CipS and CipR for 24 h. Competition fitness was monitored in vitro and in vivo in a murine peritoneal sepsis model. We showed that CipR induced less cell death than CipS and CipR growth was slow when in competition with CipS. Altogether, acquisition of ciprofloxacin resistance confers a biological fitness cost and reduces virulence in A. baumannii.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084991     DOI: 10.1111/j.1469-0691.2011.03695.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  13 in total

1.  Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.

Authors:  R Parra Millán; M E Jiménez Mejías; V Sánchez Encinales; R Ayerbe Algaba; A Gutiérrez Valencia; M E Pachón Ibáñez; C Díaz; J Pérez Del Palacio; L F López Cortés; J Pachón; Y Smani
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

4.  Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii.

Authors:  Younes Smani; Juan Domínguez-Herrera; José Ibáñez-Martínez; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

5.  Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells.

Authors:  Younes Smani; Fernando Docobo-Pérez; Rafael López-Rojas; Juan Domínguez-Herrera; José Ibáñez-Martínez; Jerónimo Pachón
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

6.  Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation.

Authors:  Jeremy A Iwashkiw; Andrea Seper; Brent S Weber; Nichollas E Scott; Evgeny Vinogradov; Chad Stratilo; Bela Reiz; Stuart J Cordwell; Randy Whittal; Stefan Schild; Mario F Feldman
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

7.  Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.

Authors:  Sunny Park; Miseon Park; Fatemeh Rafii
Journal:  BMC Microbiol       Date:  2013-03-01       Impact factor: 3.605

8.  Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.

Authors:  Ya-Sung Yang; Yi-Tzu Lee; Wen-Chiuan Tsai; Shu-Chen Kuo; Jun-Ren Sun; Chin-Hsuan Yang; Te-Li Chen; Jung-Chung Lin; Chang-Phone Fung; Feng-Yee Chang
Journal:  BMC Infect Dis       Date:  2013-07-10       Impact factor: 3.090

9.  Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program.

Authors:  Shu-Chen Kuo; Shan-Chwen Chang; Hui-Ying Wang; Jui-Fen Lai; Pei-Chen Chen; Yih-Ru Shiau; I-Wen Huang; Tsai-Ling Yang Lauderdale
Journal:  BMC Infect Dis       Date:  2012-08-28       Impact factor: 3.090

10.  Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq).

Authors:  Romain Guérillot; Lucy Li; Sarah Baines; Brian Howden; Mark B Schultz; Torsten Seemann; Ian Monk; Sacha J Pidot; Wei Gao; Stefano Giulieri; Anders Gonçalves da Silva; Anthony D'Agata; Takehiro Tomita; Anton Y Peleg; Timothy P Stinear; Benjamin P Howden
Journal:  Genome Med       Date:  2018-08-31       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.